JP2008509673A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008509673A5 JP2008509673A5 JP2007525837A JP2007525837A JP2008509673A5 JP 2008509673 A5 JP2008509673 A5 JP 2008509673A5 JP 2007525837 A JP2007525837 A JP 2007525837A JP 2007525837 A JP2007525837 A JP 2007525837A JP 2008509673 A5 JP2008509673 A5 JP 2008509673A5
- Authority
- JP
- Japan
- Prior art keywords
- sample
- marker
- expression
- patient
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60141304P | 2004-08-13 | 2004-08-13 | |
| PCT/US2005/028781 WO2006028655A2 (en) | 2004-08-13 | 2005-08-12 | Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011175448A Division JP2012024089A (ja) | 2004-08-13 | 2011-08-10 | ヒト前立腺癌の同定、評価、予防および治療のための遺伝子、組成物、キットおよび方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008509673A JP2008509673A (ja) | 2008-04-03 |
| JP2008509673A5 true JP2008509673A5 (enExample) | 2008-09-25 |
Family
ID=36036805
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007525837A Pending JP2008509673A (ja) | 2004-08-13 | 2005-08-12 | ヒト前立腺癌の同定、評価、予防および治療のための遺伝子、組成物、キットおよび方法 |
| JP2011175448A Pending JP2012024089A (ja) | 2004-08-13 | 2011-08-10 | ヒト前立腺癌の同定、評価、予防および治療のための遺伝子、組成物、キットおよび方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011175448A Pending JP2012024089A (ja) | 2004-08-13 | 2011-08-10 | ヒト前立腺癌の同定、評価、予防および治療のための遺伝子、組成物、キットおよび方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060068425A1 (enExample) |
| EP (1) | EP1784511A4 (enExample) |
| JP (2) | JP2008509673A (enExample) |
| KR (1) | KR20070052788A (enExample) |
| CN (2) | CN101018874A (enExample) |
| CA (1) | CA2576624A1 (enExample) |
| WO (1) | WO2006028655A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002337657A1 (en) * | 2001-07-25 | 2003-02-17 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| US7294704B2 (en) | 2003-08-15 | 2007-11-13 | Diadexus, Inc. | Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk |
| AU2005245815B2 (en) | 2004-05-07 | 2011-06-09 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer |
| CA2622295C (en) | 2005-09-12 | 2019-01-15 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
| US9957569B2 (en) * | 2005-09-12 | 2018-05-01 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
| CN1903876B (zh) * | 2006-07-10 | 2010-09-01 | 郑鸿 | 一种多肽、编码它的核酸分子及用途 |
| CN101652484B (zh) * | 2006-11-08 | 2013-03-20 | 密歇根大学董事会 | 前列腺癌标志物spink1及其应用 |
| EP2155897A2 (en) * | 2007-03-30 | 2010-02-24 | Source Precision Medicine, Inc. d/b/a Source MDX. | Gene expression profiling for identification, monitoring, and treatment of prostate cancer |
| ATE533861T1 (de) | 2007-07-06 | 2011-12-15 | Univ Michigan | Mipol1-etv1-gen-neuanordnungen |
| US20110047634A1 (en) * | 2008-02-22 | 2011-02-24 | St. Jude Children's Research Hospital | Methods and compositions for the diagnosis and treatment of acute lymphoblastic leukemia |
| KR101018665B1 (ko) * | 2008-08-18 | 2011-03-04 | 재단법인서울대학교산학협력재단 | 전립선암 진단 방법 및 장치 |
| ES2495367T3 (es) | 2009-04-29 | 2014-09-17 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Anticuerpos monoclonales de ERG |
| KR20120036842A (ko) * | 2009-05-12 | 2012-04-18 | 코닌클리케 필립스 일렉트로닉스 엔.브이. | 악성의 호르몬 민감성 전립선 암에 대한 마커로서의 포스포디에스테라제 4ｄ7 |
| EP3133168B1 (en) * | 2009-05-26 | 2019-01-23 | Quest Diagnostics Investments Incorporated | Methods for detecting gene dysregulations |
| AU2010295689B2 (en) | 2009-09-17 | 2014-02-13 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
| US8546552B2 (en) | 2009-12-23 | 2013-10-01 | Quest Diagnostics Investments Incorporated | TMPRSS2 for the diagnosis of prostate disease |
| WO2011085002A1 (en) * | 2010-01-05 | 2011-07-14 | University Of Cincinnati | Serum spla2-iia as diagnosis marker for prostate and lung cancer |
| WO2012015765A2 (en) | 2010-07-27 | 2012-02-02 | Genomic Health, Inc. | Method for using gene expression to determine prognosis of prostate cancer |
| US8945556B2 (en) | 2010-11-19 | 2015-02-03 | The Regents Of The University Of Michigan | RAF gene fusions |
| CN103797120B (zh) * | 2011-09-16 | 2017-04-12 | 上海长海医院 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
| HK1201881A1 (en) | 2012-01-31 | 2015-09-11 | Genomic Health, Inc. | Gene expression profile algorithm and test for determining prognosis of prostate cancer |
| JP5429725B1 (ja) * | 2013-03-22 | 2014-02-26 | 独立行政法人理化学研究所 | 前立腺癌の進行度の評価方法、前立腺癌の検出方法、および検査キット |
| CA2969154A1 (en) * | 2014-12-01 | 2016-06-09 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Novel rna-biomarker signature for diagnosis of prostate cancer |
| ES3007999T3 (en) * | 2015-04-21 | 2025-03-21 | Genentech Inc | Compositions and methods for prostate cancer analysis |
| CN109198732A (zh) * | 2018-08-20 | 2019-01-15 | 苏州晞光生物科技有限公司 | 一种智能化可穿戴检测人体分泌物的服装及测试方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6972170B1 (en) * | 1997-12-01 | 2005-12-06 | Sloan-Kettering Institute For Cancer Research | Markers for prostate cancer |
| ES2529300T3 (es) * | 2000-04-12 | 2015-02-18 | Novozymes Biopharma Dk A/S | Proteínas de fusión de albúmina |
| KR100359941B1 (ko) * | 2000-04-14 | 2002-11-07 | 엘지전자 주식회사 | 바이오칩 제조방법 |
| DE60231110D1 (de) * | 2001-04-02 | 2009-03-26 | Develogen Ag | Proteindisulfidisomerase und abc-transporter-homologe proteine, die an der regulierung der energie-homeostase beteiligt sind |
| US20030138793A1 (en) * | 2001-06-10 | 2003-07-24 | Irm Llc, A Delaware Limited Liability Company | Molecular signatures of commonly fatal carcinomas |
| AU2002337657A1 (en) | 2001-07-25 | 2003-02-17 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| US6949342B2 (en) * | 2001-12-21 | 2005-09-27 | Whitehead Institute For Biomedical Research | Prostate cancer diagnosis and outcome prediction by expression analysis |
| AU2003237779B2 (en) * | 2002-02-13 | 2008-06-26 | American Diagnostica Inc. | Methods for selecting treatment regimens and predicting outcomes in cancer patients |
| US20040029151A1 (en) * | 2002-04-09 | 2004-02-12 | Affymetrix, Inc. | Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer |
| DE10234901A1 (de) * | 2002-07-26 | 2004-02-12 | Metagen Pharmaceuticals Gmbh | Verwendung von am Mrp4 bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen |
-
2005
- 2005-08-12 KR KR1020077005721A patent/KR20070052788A/ko not_active Ceased
- 2005-08-12 US US11/203,526 patent/US20060068425A1/en not_active Abandoned
- 2005-08-12 CA CA002576624A patent/CA2576624A1/en not_active Abandoned
- 2005-08-12 CN CNA2005800308632A patent/CN101018874A/zh active Pending
- 2005-08-12 CN CN2012101370191A patent/CN102680686A/zh active Pending
- 2005-08-12 WO PCT/US2005/028781 patent/WO2006028655A2/en not_active Ceased
- 2005-08-12 EP EP05807825A patent/EP1784511A4/en not_active Ceased
- 2005-08-12 JP JP2007525837A patent/JP2008509673A/ja active Pending
-
2011
- 2011-08-10 JP JP2011175448A patent/JP2012024089A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008509673A5 (enExample) | ||
| CN117965692A (zh) | 通过基于生物流体的无细胞dna（cfdna）测定评价器官损伤状态的基于免疫探针的新方法 | |
| US20130040852A1 (en) | Biomarkers based on a multi-cancer invasion-associated mechanism | |
| US20140005070A1 (en) | Markers associated with cyclin-dependent kinase inhibitors | |
| JP6285009B2 (ja) | 前立腺ガンの予後の検知及び判定のための組成物及び該検知及び判定方法 | |
| JP2012525855A5 (enExample) | ||
| JP2013505429A5 (enExample) | ||
| CA2882759A1 (en) | Detection of the ntrk1-mprip gene fusion for cancer diagnosis | |
| JP2010508855A5 (enExample) | ||
| JP2004509643A (ja) | アルキル化剤を用いた化学療法による治療に対する臨床反応を予測する方法 | |
| JP2013500001A5 (enExample) | ||
| JP6387001B2 (ja) | Ｃｄｋ阻害剤と関連するバイオマーカー | |
| JP2008512984A5 (enExample) | ||
| US20220162710A1 (en) | Composition for diagnosis or prognosis prediction of glioma, and method for providing information related thereto | |
| JP2009539370A5 (enExample) | ||
| DE60325541D1 (de) | Verfahren/Präparat zur Erkennung von Pankreaskrebs | |
| IL285031A (en) | Diagnosis of inflammatory bowel diseases | |
| WO2011093606A2 (ko) | Pna 기반의 실시간 pcr 클램핑을 이용한 braf 돌연변이 검출 방법 및 키트 | |
| CN108913772B (zh) | 基于捕获测序的bMSI检测技术 | |
| JP3677210B2 (ja) | 前立腺がんを診断し、モニターし、そして病期決定する新規な方法 | |
| WO2014176047A1 (en) | Markers for ezh2 inhibitors | |
| JP2009524051A5 (enExample) | ||
| JP7150018B2 (ja) | 新規なｃｉｐ２ａバリアント及びその使用 | |
| US20130288918A1 (en) | Colorectal Cancer Screening Method | |
| KR20170074034A (ko) | 간 섬유화 진단용 바이오마커 cxcl14 |